NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Voyager Therapeutics Inc (NASDAQ: VYGR)

 
VYGR Technical Analysis
5
As on 9th Jun 2023 VYGR STOCK Price closed @ 12.97 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 5.67 & Strong Buy for SHORT-TERM with Stoploss of 3.15 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VYGRSTOCK Price

Open 12.84 Change Price %
High 13.04 1 Day 0.18 1.41
Low 12.62 1 Week 0.92 7.63
Close 12.97 1 Month 5.45 72.47
Volume 411400 1 Year 9.98 333.78
52 Week High 13.85 | 52 Week Low 2.70
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
VYGR
Daily Charts
VYGR
Intraday Charts
Whats New @
Bazaartrend
VYGR
Free Analysis
 
VYGR Important Levels Intraday
RESISTANCE13.78
RESISTANCE13.52
RESISTANCE13.36
RESISTANCE13.20
SUPPORT12.74
SUPPORT12.58
SUPPORT12.42
SUPPORT12.16
 
VYGR Forecast May 2024
4th UP Forecast15.11
3rd UP Forecast14.42
2nd UP Forecast14
1st UP Forecast13.57
1st DOWN Forecast12.37
2nd DOWN Forecast11.94
3rd DOWN Forecast11.52
4th DOWN Forecast10.83
 
VYGR Weekly Forecast
4th UP Forecast13.55
3rd UP Forecast13.36
2nd UP Forecast13.25
1st UP Forecast13.13
1st DOWN Forecast12.81
2nd DOWN Forecast12.69
3rd DOWN Forecast12.58
4th DOWN Forecast12.39
 
VYGR Forecast2024
4th UP Forecast35.59
3rd UP Forecast28.34
2nd UP Forecast23.85
1st UP Forecast19.37
1st DOWN Forecast6.57
2nd DOWN Forecast2.09
3rd DOWN Forecast-2.4
4th DOWN Forecast-9.65
 
 
VYGR Other Details
Segment EQ
Market Capital 139603008.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VYGR Address
VYGR
 
VYGR Latest News
 
Your Comments and Response on Voyager Therapeutics Inc
 
VYGR Business Profile
Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe neurological diseases. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1b clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau program for the treatment of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia. The company has strategic collaboration agreements with the University of Massachusetts; and ClearPoint Neuro, Inc., as well as collaborations with Thermo Fisher Scientific and Fujifilm Diosynth Biotechnologies to support the development of its gene therapy programs. It also has a collaboration and license agreement with Neurocrine Biosciences, Inc. for the research, development, and commercialization of adeno-associated virus-based gene therapy products. Voyager Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts. Address: 75 Sidney Street, Cambridge, MA, United States, 02139
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service